About AIDPATH AIDPATH stands for AI powered, Decentralized Production for Advanced Therapies in the Hospital. In the EU project AIDPATH, researchers are developing a system for the production of so-called CAR-T cells for the treatment of cancer. It is capable of integrating patient-related data and biomarkers into the therapy process using artificial intelligence. The CAR-T cells are produced close to the patient, directly in the hospital. This will make it possible in the future to provide patients treatments specifically tailored to their needs much more quickly. About the CAR-T-cell therapy in AIDPATH The automated CAR-T cell production consists of heterogeneous machines and devices that are connected via standardized interfaces in a so-called integration framework. All devices are controlled by service-oriented control software, which enables centralized management and monitoring of processes. The control software is supported by an AI-based digital cell twin that defines initial process parameters and an AI process controller that adjusts process parameters during operation.